Published in Biomaterials on August 11, 2012
A polymer-extracellular matrix composite with improved thromboresistance and recellularization properties. Acta Biomater (2015) 0.88
Human progenitor cell recruitment via SDF-1α coacervate-laden PGS vascular grafts. Biomaterials (2013) 0.86
Biomaterials in cardiovascular research: applications and clinical implications. Biomed Res Int (2014) 0.82
In vivo capture and label-free detection of early metastatic cells. Nat Commun (2015) 0.81
Successful endothelialization and remodeling of a cell-free small-diameter arterial graft in a large animal model. Biomaterials (2015) 0.81
Dysregulated miR-361-5p/VEGF axis in the plasma and endothelial progenitor cells of patients with coronary artery disease. PLoS One (2014) 0.80
Accelerating in situ endothelialisation of cardiovascular bypass grafts. Int J Mol Sci (2014) 0.79
A cautionary tale for autologous vascular tissue engineering: impact of human demographics on the ability of adipose-derived mesenchymal stem cells to recruit and differentiate into smooth muscle cells. Tissue Eng Part A (2014) 0.79
Layer-by-layer heparinization of decellularized liver matrices to reduce thrombogenicity of tissue engineered grafts. J Clin Transl Res (2015) 0.77
Capture of endothelial cells under flow using immobilized vascular endothelial growth factor. Biomaterials (2015) 0.77
Stem Cells on Biomaterials for Synthetic Grafts to Promote Vascular Healing. J Clin Med (2014) 0.76
Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling. Glycoconj J (2015) 0.75
Sox10(+) adult stem cells contribute to biomaterial encapsulation and microvascularization. Sci Rep (2017) 0.75
End-Point Immobilization of Heparin on Plasma-Treated Surface of Electrospun Polycarbonate-Urethane Vascular Graft. Acta Biomater (2017) 0.75
Mucin covalently bonded to microfibers improves the patency of vascular grafts. Tissue Eng Part A (2013) 0.75
Delivery of stromal cell-derived factor 1α for in situ tissue regeneration. J Biol Eng (2017) 0.75
Cell-free vascular grafts: Recent developments and clinical potential. Technology (Singap World Sci) (2017) 0.75
A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell (2008) 18.18
VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell (2006) 9.32
Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med (2003) 7.14
Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet (2003) 6.85
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J (1999) 6.62
Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation (2003) 5.20
Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation (2004) 4.79
Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med (2006) 3.39
SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood (2004) 3.16
Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest (2004) 3.02
Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg (2005) 2.83
Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A (2010) 2.49
Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood (2002) 2.43
Small-diameter artificial arteries engineered in vitro. Circ Res (2006) 2.40
Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J Biol Chem (1999) 2.32
Multilineage potential of cells from the artery wall. Circulation (2003) 2.17
Readily available tissue-engineered vascular grafts. Sci Transl Med (2011) 2.13
Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci U S A (2007) 2.01
Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J (2008) 1.97
Electrospinning collagen and elastin: preliminary vascular tissue engineering. Front Biosci (2004) 1.96
Prosthetic vascular grafts: wrong models, wrong questions and no healing. Biomaterials (2007) 1.84
Bioactive nanofibers: synergistic effects of nanotopography and chemical signaling on cell guidance. Nano Lett (2007) 1.81
Transplantation of an allogeneic vein bioengineered with autologous stem cells: a proof-of-concept study. Lancet (2012) 1.81
Vascular tissue engineering. Annu Rev Biomed Eng (2001) 1.80
Controlled fabrication of a biological vascular substitute. Biomaterials (2005) 1.76
Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells (2010) 1.74
Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat Commun (2012) 1.66
Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin. J Biol Chem (2007) 1.58
Silk-based electrospun tubular scaffolds for tissue-engineered vascular grafts. J Biomater Sci Polym Ed (2008) 1.55
Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J Biol Chem (2004) 1.51
Development of a tissue-engineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique. Biomaterials (2007) 1.48
Characterization of the stromal cell-derived factor-1alpha-heparin complex. J Biol Chem (2000) 1.46
Isolation of "side population" progenitor cells from healthy arteries of adult mice. Arterioscler Thromb Vasc Biol (2005) 1.31
Vascular progenitors: from biology to treatment. Trends Cardiovasc Med (2002) 1.18
Antithrombogenic modification of small-diameter microfibrous vascular grafts. Arterioscler Thromb Vasc Biol (2010) 1.12
Long-term experience in autologous in vitro endothelialization of infrainguinal ePTFE grafts. J Vasc Surg (2008) 1.12
Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation. Biomaterials (2010) 1.09
Vascular tissue engineering: the next generation. Trends Mol Med (2012) 1.03
Nonthrombogenic approaches to cardiovascular bioengineering. Annu Rev Biomed Eng (2011) 0.97
Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells. Gene Ther (2002) 0.95
Improved endothelialization and reduced thrombosis by coating a synthetic vascular graft with fibronectin and stem cell homing factor SDF-1α. Acta Biomater (2011) 0.93
Results from an Italian multicentric registry comparing heparin-bonded ePTFE graft and autologous saphenous vein in below-knee femoro-popliteal bypasses. J Cardiovasc Surg (Torino) (2012) 0.84
Genome sequence of Aedes aegypti, a major arbovirus vector. Science (2007) 9.19
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst (2006) 6.73
Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression. EMBO J (2002) 2.46
Anisotropic mechanosensing by mesenchymal stem cells. Proc Natl Acad Sci U S A (2006) 2.43
Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology (2007) 2.43
Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells. Int J Cancer (2004) 2.31
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol (2011) 2.19
A new insight into membrane fouling mechanism in submerged membrane bioreactor: osmotic pressure during cake layer filtration. Water Res (2013) 2.07
Boolean network simulations for life scientists. Source Code Biol Med (2008) 2.05
Differential effects of equiaxial and uniaxial strain on mesenchymal stem cells. Biotechnol Bioeng (2004) 2.05
The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC Cancer (2009) 2.01
Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci U S A (2007) 2.01
Myotube assembly on nanofibrous and micropatterned polymers. Nano Lett (2006) 2.00
Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor beta1 stimulation. J Biol Chem (2004) 1.96
The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-β. Biomaterials (2011) 1.93
Bioactive nanofibers: synergistic effects of nanotopography and chemical signaling on cell guidance. Nano Lett (2007) 1.81
Rho mediates the shear-enhancement of endothelial cell migration and traction force generation. Biophys J (2004) 1.77
Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells (2010) 1.74
Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat Commun (2012) 1.66
Regulation of vascular smooth muscle cells by micropatterning. Biochem Biophys Res Commun (2003) 1.63
Biophysical regulation of epigenetic state and cell reprogramming. Nat Mater (2013) 1.55
Cationic lipids enhance siRNA-mediated interferon response in mice. Biochem Biophys Res Commun (2005) 1.50
Sporadic onset of erythermalgia: a gain-of-function mutation in Nav1.7. Ann Neurol (2006) 1.48
Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng (2006) 1.46
PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells. Proc Natl Acad Sci U S A (2004) 1.42
Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. J Cereb Blood Flow Metab (2007) 1.39
Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage. Stroke (2007) 1.38
Arsenic-stimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide. J Clin Invest (2008) 1.33
Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. Carcinogenesis (2007) 1.30
MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251. Arch Med Res (2010) 1.30
Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat (2008) 1.26
Differential regulation of Rho GTPases by beta1 and beta3 integrins: the role of an extracellular domain of integrin in intracellular signaling. J Cell Sci (2002) 1.24
MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations. Front Biosci (2006) 1.24
Boolean modeling of transcriptome data reveals novel modes of heterotrimeric G-protein action. Mol Syst Biol (2010) 1.23
VEGF Induces More Severe Cerebrovascular Dysplasia in Endoglin than in Alk1 Mice. Transl Stroke Res (2010) 1.23
Common and unique elements of the ABA-regulated transcriptome of Arabidopsis guard cells. BMC Genomics (2011) 1.21
Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China. Birth Defects Res A Clin Mol Teratol (2006) 1.21
Role of cell surface heparan sulfate proteoglycans in endothelial cell migration and mechanotransduction. J Cell Physiol (2005) 1.20
Synthesis of a series of novel 2,4,5-trisubstituted selenazole compounds as potential PLTP inhibitors. Bioorg Med Chem Lett (2010) 1.20
Biomimetic collagen scaffolds for human bone cell growth and differentiation. Tissue Eng (2004) 1.19
Cell-shape regulation of smooth muscle cell proliferation. Biophys J (2009) 1.19
miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. J Hepatol (2012) 1.19
Neutrophil depletion decreases VEGF-induced focal angiogenesis in the mature mouse brain. J Cereb Blood Flow Metab (2007) 1.17
Inhibition of Pkhd1 impairs tubulomorphogenesis of cultured IMCD cells. Mol Biol Cell (2005) 1.17
Dual role of orphan nuclear receptor pregnane X receptor in bilirubin detoxification in mice. Hepatology (2005) 1.17
Interplay between integrins and FLK-1 in shear stress-induced signaling. Am J Physiol Cell Physiol (2002) 1.17
A rodent model of myocardial infarction for testing the efficacy of cells and polymers for myocardial reconstruction. Nat Protoc (2006) 1.16
Beclin 1-independent autophagy induced by a Bcl-XL/Bcl-2 targeting compound, Z18. Autophagy (2010) 1.15
Biophysical regulation of histone acetylation in mesenchymal stem cells. Biophys J (2011) 1.14
Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil. Breast Cancer Res Treat (2006) 1.14
An ana2/ctp/mud complex regulates spindle orientation in Drosophila neuroblasts. Dev Cell (2011) 1.13
Regulation of vascular smooth muscle cells and mesenchymal stem cells by mechanical strain. Mol Cell Biomech (2006) 1.13
A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese population. J Cancer Res Clin Oncol (2010) 1.13
Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells. Circ Res (2005) 1.12
Antithrombogenic modification of small-diameter microfibrous vascular grafts. Arterioscler Thromb Vasc Biol (2010) 1.12
Molecular basis of mechanical modulation of endothelial cell migration. Front Biosci (2005) 1.12
Induced pluripotent stem cells for neural tissue engineering. Biomaterials (2011) 1.11
Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis. Cancer Res (2006) 1.11
Androgen deprivation by activating the liver X receptor. Endocrinology (2008) 1.10
Deep sequencing of maize small RNAs reveals a diverse set of microRNA in dry and imbibed seeds. PLoS One (2013) 1.09
Mastering translational medicine: interdisciplinary education for a new generation. Sci Transl Med (2014) 1.08
Inhibition of LPS- and CpG DNA-induced TNF-alpha response by oxidized phospholipids. Am J Physiol Lung Cell Mol Physiol (2003) 1.08
Engineering bi-layer nanofibrous conduits for peripheral nerve regeneration. Tissue Eng Part C Methods (2011) 1.08
FXR-mediated regulation of eNOS expression in vascular endothelial cells. Cardiovasc Res (2007) 1.06
Methyl-naltrexone bromide methanol monosolvate. Acta Crystallogr Sect E Struct Rep Online (2012) 1.06
Mesenchymal stem cells for vascular regeneration. Regen Med (2008) 1.06
Identification of a novel IRGM promoter single nucleotide polymorphism associated with tuberculosis. Clin Chim Acta (2010) 1.06
MicroRNA hsa-miR-613 targets the human LXRα gene and mediates a feedback loop of LXRα autoregulation. Mol Endocrinol (2011) 1.05
The effect of fiber alignment and heparin coating on cell infiltration into nanofibrous PLLA scaffolds. Biomaterials (2010) 1.05
Intraesophageal administration of GS-nitroxide (JP4-039) protects against ionizing irradiation-induced esophagitis. In Vivo (2010) 1.05
Roles of microtubule dynamics and small GTPase Rac in endothelial cell migration and lamellipodium formation under flow. J Vasc Res (2003) 1.04
PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel. Bioconjug Chem (2012) 1.04
LPD nanoparticles--novel nonviral vector for efficient gene delivery. Methods Mol Med (2002) 1.03
PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers. Biomaterials (2012) 1.03
Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kappaB signaling pathway. Mol Cell Biochem (2009) 1.02
Qdot nanobarcodes for multiplexed gene expression analysis. Nano Lett (2006) 1.02
In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells. Mol Cancer Ther (2005) 1.02
A novel Bcl-XL inhibitor Z36 that induces autophagic cell death in Hela cells. Autophagy (2009) 1.02
Selective adapter recruitment and differential signaling networks by VEGF vs. shear stress. Proc Natl Acad Sci U S A (2007) 1.00
An improved method for isolating Schwann cells from postnatal rat sciatic nerves. Cell Tissue Res (2009) 1.00
Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel. Mol Pharm (2013) 1.00
CpG DNA-mediated immune response in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol (2004) 1.00
The association of GSK3 beta with E2F1 facilitates nerve growth factor-induced neural cell differentiation. J Biol Chem (2008) 1.00
Salubrinal protects against tunicamycin and hypoxia induced cardiomyocyte apoptosis via the PERK-eIF2α signaling pathway. J Geriatr Cardiol (2012) 1.00
The relationship between Cho/NAA and glioma metabolism: implementation for margin delineation of cerebral gliomas. Acta Neurochir (Wien) (2012) 0.98
A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families. Hum Mutat (2002) 0.98
Glucose and lipid metabolism in small-for-gestational-age infants at 72 hours of age. J Clin Endocrinol Metab (2006) 0.98
catena-Poly[[tris-(pyridine-κN)copper(II)]-μ-tetra-fluoro-terephthalato-κO:O]. Acta Crystallogr Sect E Struct Rep Online (2008) 0.97
XRCC3 haplotypes and risk of gliomas in a Chinese population: a hospital-based case-control study. Int J Cancer (2009) 0.97
PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel. Bioconjug Chem (2013) 0.96